Order results by:
| Issue | Title | |
| Vol 7, No 4 (2014) | IS RUSSIA READY FOR THE INTRODUCTION OF THE NATIONAL REFERENCE PRICING SYSTEM? | Abstract similar documents |
| V. V. Omelyanovskiy | ||
| "... the analysis of foreign pricing and drug supply public funding systems (or a so-called drug ..." | ||
| Vol 17, No 4 (2024) | Dynamics of anticancer drug use in Russian hospitals: a five-year retrospective analysis | Abstract similar documents |
| J. A. Agafonova, V. V. Omelyanovskiy | ||
| "... issues, particularly the use of oral anticancer drugs (ACDs) in day hospitals. These facilities often ..." | ||
| Vol 7, No 4 (2014) | APPLICATION OF MULTIPLE-CRITERIA ANALYSIS FOR OPTIMIZATION OF FINANCING OF RARE DISEASES | Abstract similar documents |
| V. V. Omelyanovskiy, V. K. Fedyaeva, O. Yu. Rebrova | ||
| "... financing of rare disease drugs remains a serious problem for both foreign countries and our ..." | ||
| Vol 8, No 2 (2015) | PRINCIPLES OF IMPORT SUBSTITUTION REGARDING DRUGS | Abstract similar documents |
| Alana Viktorovna Dzaneva, Vitalii Vladimirovich Omel'yanovskii, Saniyat Aleksandrovna Kagermazova | ||
| "... This articles is devoted to major principles of import substitution regarding drugs within ..." | ||
| Online First | Methodology approach to developing criteria for selecting hemophilia drugs included in the High-Cost Nosology program | Abstract similar documents |
| A. G. Kharitonova, V. V. Omelyanovskiy, K. I. Matrenin, A. A. Kingshott | ||
| "... Nosologies (HCN), which ensures nationwide access to expensive drug therapies funded from the federal budget ..." | ||
| Vol 11, No 3 (2018) | The concept of multi-criteria analysis of decision-making in the current system of health technology assessment in Russia | Abstract similar documents |
| V. V. Omelyanovsky, V. K. Fedyaeva, N. Z. Musina | ||
| Online First | Use of real‑world evidence in comprehensive drug assessment | Abstract similar documents |
| F. V. Gorkavenko, V. V. Omelyanovskiy, A. V. Nikitina, A. A. Slabikova | ||
| "... ‑world evidence (RWE) underscore the need for its broader integration in comprehensive drug assessment ..." | ||
| Vol 7, No 4 (2014) | ROAD MAP FOR DEVELOPMENT OF PRICE REGULATION SYSTEM AND SYSTEM OF DRUG SUPPLY AT THE EXPENSE OF RUSSIAN FEDERATION HEALTHCARE SYSTEM FUNDS | Abstract similar documents |
| M. V. Sura, K. V. Gerasimova, V. V. Omelyanovskiy, M. V. Avksentieva | ||
| "... study goal is to prepare a road map for development of price regulation system and system of drug ..." | ||
| Vol 7, No 3 (2014) | ASSESSMENT OF NECESSARY FINANCIAL EXPENSES ON THE DRUG SUPPLY OF THE PATIENTS WITH ORPHAN DISEASES IN THE RUSSIAN FEDERATION | Abstract similar documents |
| M. V. Sura, K. V. Gerasimova, V. V. Omelyanovskiy, M. V. Avksentyeva | ||
| "... the article presents the results of cost calculation on the drug supply of the patients ..." | ||
| Vol 12, No 2 (2019) | Health technology assessment and reimbursement of pharmaceuticals in Italy | Abstract similar documents |
| F. V. Gorkavenko, V. V. Omelyanovskiy, T. P. Bezdenezhnykh, G. R. Khachatryan | ||
| Vol 12, No 4 (2019) | The health technology assessment system in Australia | Abstract similar documents |
| V. V. Omelyanovskiy, E. S. Saybel, T. P. Bezdenezhnykh, G. R. Khachatryan | ||
| "... by the federal budget. The drug evaluation process includes five stages: a review of general information about ..." | ||
| Vol 18, No 3 (2025) | Results of the survey of experts on the need to incorporate real-world evidence to the comprehensive drug assessment | Abstract similar documents |
| F. V. Gorkavenko, V. V. Omelyanovskiy | ||
| "... ) a promising path for improving comprehensive drug assessment (CDA). Therefore, it is particularly important ..." | ||
| Vol 9, No 3 (2016) | DRUGS PROVIDED TO BREAST CANCER PATIENTS WITHIN THE STATE PROGRAMS OF DRUG SUPPLY | Abstract similar documents |
| M. V. Avxentyeva, V. I. Bogin, E. V. Derkach, V. V. Omelyanovskiy, M. B. Stenina, A. V. Tarakanov, M. Yu. Frolov | ||
| "... cancer in various regions of the Russian Federation in the framework of state programs of drug provision ..." | ||
| Vol 13, No 2 (2020) | Improvements to the formation of lists of drugs for medical use: analysis of changes in the Government Decree no. 871 | Abstract similar documents |
| V. V. Omelyanovskiy, E. A. Maksimkina, O. I. Ivakhnenko, M. V. Avxentyeva, M. V. Sura, G. R. Khachatryan | ||
| "... development of approaches for complex drug assessment in Russia, also criteria for its evaluation were under ..." | ||
| Vol 17, No 3 (2024) | Assessment of the impact of procurement centralization on the drug provision for patients within the High-Cost Nosology Program in the Russian Federation | Abstract similar documents |
| V. V. Omelyanovskiy, V. A. Ryagina, A. G. Kharitonova, K. I. Matrenin, A. A. Kingshott, O. V. Ashikhmina, M. V. Zhirov | ||
| "... Background. In the Russian Federation, patients receive expensive drugs from the federal budget ..." | ||
| Vol 14, No 1 (2021) | Development of a method for the analysis of the lists of medicines and its application for the analysis of the lists of medicines in Russia, England, and Italy | Abstract similar documents |
| V. A. Lemeshko, K. I. Matrenin, V. V. Omelyanovskiy, Yu. V. Vasilyeva, G. R. Khachatryan, L. A. Kolganov | ||
| "... and Italy exceeds the total number of drugs included in the list of vital essential and desirable (VED ..." | ||
| Vol 13, No 2 (2020) | Affordability of in vivo gene therapy. Problems and potential solutions | Abstract similar documents |
| V. V. Omelyanovskiy, N. Z. Musina, V. A. Lemeshko, A. A. Antonov, F. V. Gorkavenko | ||
| "... Aim. To review foreign approaches to the evaluation and financing of in vivo gene therapy drugs ..." | ||
| Vol 16, No 2 (2023) | Improving the model of payment for medical care for chronic viral hepatitis C in the framework of the implementation of the Program of State Guarantees of Free Provision of Medical Care to Citizens for 2023 and for the planned period of 2024–2025 | Abstract similar documents |
| V. V. Omelyanovskiy, I. A. Zheleznyakova, A. V. Zuev, O. S. Plakhotnik, O. A. Volkova, L. M. Davydova, G. V. Trifonova, E. V. Semakova, E. A. Prokhorovich, A. S. Volkova | ||
| "... ) in adults were published that did not contain interferon drug therapy regimens. Current therapy of chronic ..." | ||
| Vol 16, No 2 (2023) | Real-world data: principles of use in decision making and in health technology assessment | Abstract similar documents |
| V. V. Omelyanovskiy, F. V. Gorkavenko, N. V. Ignatyeva, P. A. Mukhortova, O. R. Ryzhova, T. S. Teptsova, A. A. Kingshott, B. B. Kondratyeva | ||
| "... as the ways of their use in complex drug assessment. ..." | ||
| 1 - 20 of 20 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)






























